Variantyx logo

Variantyx Funding & Investors

Framingham, MA

Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.

variantyx.com

Total Amount Raised: $136,500,000

Variantyx Funding Rounds

  • Series D

    $36,000,000

    Series D Investors

    New Era Capital Partners
    Peregrine Ventures
    Robert Bosch Venture Capital
    Pitango Venture Capital
  • Debt Financing

    $20,000,000

    Debt Financing Investors

    Kreos Capital
  • Series C

    $41,500,000

    Series C Investors

    New Era Capital Partners
    Robert Bosch Venture Capital
    Peregrine Ventures
    20/20 Healthcare Partners
    Pitango Venture Capital
  • Series C

    $6,000,000

    Series C Investors

    Robert Bosch Venture Capital
  • Series C

    $20,000,000

    Series C Investors

    Global health sciences venture fund
    IBM Ventures
    Pitango Venture Capital
    New Era Capital Partners
    20/20 Healthcare Partners
  • Series B

    $10,000,000

    Series B Investors

    Pitango Venture Capital
    New Era Capital Partners
  • Series A

    $3,000,000

Funding info provided by Diffbot.